Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
333.5 USD | +2.58% |
|
+7.18% | +15.69% |
03:31pm | UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating | MT |
Jul. 11 | Morgan Stanley Adjusts Price Target on Amgen to $303 From $310 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.65% | 174B | |
+62.57% | 841B | |
+40.42% | 625B | |
-3.88% | 360B | |
+17.66% | 327B | |
+10.23% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+0.96% | 162B | |
+5.17% | 127B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating